BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » adipose-derived stem cells

Diversifying Cord Blood Banking through Adipose-Derived Stem Cell Storage

August 1, 2020 By Cade Hildreth (CEO) 1 Comment

4 Key Definitions that Will Improve Market Research for the Stem Cell Biobanking Market

The global cord blood banking industry has been rapidly maturing in recent years. In part, this has been caused by changes in processing, storage, and transplantation technologies. These changes require executives and industry decision-makers to have a firm understanding of emerging trends.

One of the most notable cord blood industry trends has been a diversification of services. Put simply, cord blood banks are becoming diversified stem cell biobanks. [Read more…]

Filed Under: Adipose SCs, Cord Blood, MSCs Tagged With: adipose-derived stem cells, American Cryostem, biobanking, stem cells

Key Market Leaders for Adipose-Derived Mesenchymal Stem Cell (MSC) Storage

August 18, 2016 By Cade Hildreth (CEO) Leave a Comment

Key Market Leaders for Adipose-Derived Mesenchymal Stem Cell (MSC) Storage - Depositphotos_63832383_m-2015

In addition to cord tissue storage, many cord blood banks are now investigating the addition of adipose-derived stem cell storage.

It is a logical product extension for cord blood banks, given that a range of collection, processing, and storage equipment is already present within the facility.

Additionally, conversion costs to allow for adipose-derived stem cell storage can be as low as USD $100,000 to $150,000.

The conversion of a cord blood facility to be able to offer adipose-derived stem cell storage can be efficiently accomplished through collaboration with a specialist in the area of adipose tissue extraction and storage.

Companies such as American Cryostem in the United States have been willing to partner with cord blood banks to assist them with adding adipose-derived MSC storage as a service.

Leading Companies Offering Mesenchymal Stem Cell (MSC) Storage

Below is an analysis of both diversified cord blood banks and specialty companies that currently offer adipose-derived stem cell storage. [Read more…]

Filed Under: Adipose SCs, Cord Blood, MSCs, Stem Cells Tagged With: adipose-derived stem cell storage, adipose-derived stem cells, cord blood, cord blood banks

Setting the Standard in Adipose-Derived Stem Cell Applications

August 15, 2016 By Cade Hildreth (CEO) Leave a Comment

Okyanos, Stem Cell Therapy
Matthew Feshbach, CEO and Co-Founder of Okyanos
Matthew Feshbach, CEO and Co-Founder of Okyanos

This article is part two of my interview with Matthew Feshbach, CEO and Co-Founder of Okyanos (pronounced “Oh – key – AH – nos”). Founded in 2011, Okyanos specializes in treating patients with chronic, degenerative conditions. Located in Freeport, Grand Bahama, just 55 miles from the United States, Okyanos Cell Therapy combines a blend of stem and regenerative cells derived from a patient’s own adipose (fat) tissue.

Treatment is performed in their state-of-the-art surgical center by a team of U.S. licensed medical doctors. Okyanos is also fully licensed under the Bahamas Stem Cell Therapy and Research Act and adheres to U.S. surgical center standards.

Using technology from Cytori Therapeutics, the company offers a highly characterized cellular product that is administered via a robust protocol by a renowned medical team within a world-class facility. It is my opinion, that Okyanos is a company that is setting the standard for others practicing cellular therapy with adipose-derived stem and regenerative cells.

Enjoy this second half of the interview. If you haven’t read it yet, click here to view Part 1. [Read more…]

Filed Under: Adipose SCs, Interviews, MSCs, Stem Cells Tagged With: adipose-derived stem cells, cell therapy, Matthew Feshbach, mesenchymal stem cells, Okyanos, Q&A

Mesenchymal Stem Cell Industry News Round Up | June 2015

June 22, 2015 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal Stem Cell Current Events

The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for June 2015.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: adipose-derived stem cells, Ampion, current events, cystic fibrosis, industry news, mesenchymal stem cells, osteoblasts, osteoporosis, Stemedica

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.